Please note that W-BAD is not affiliated with any of the following organizations, nor are they affiliated with W-BAD. They are listed here for educational and awareness purposes, where individuals interested in iatrogenic benzodiazepine dependency and withdrawal can acquire more information.

Benzodiazepine Information Coalition (BIC)


Founded in 2016 out of Midvale, UT, Benzodiazepine Information Coalition’s mission is educating about the potential adverse effects of benzodiazepines taken as prescribed. This 501(c)3 non-profit organization is comprised of physicians, psychologists, pharmacists, and patients—engaging the public, media, medical community, and lawmakers in an effort to raise awareness about the dangers associated with benzodiazepines. The Coalition is particularly interested in the harmful effects of the drug on patients who have taken it exactly as prescribed.

Support BIC and their initiatives with a tax-deductible, charitable donation.

Follow BIC to learn more about their organization and initiatives—both ongoing and upcoming.



From their website:

LADER-ASHTON.org exists to help guide patients and professionals in recognizing central nervous system dysfunction associated with normal-dose benzodiazepine dependency and withdrawal. It most commonly affects patients who took the medication as prescribed and whom do not have a history of addiction or a substance abuse disorder. However, it can co-occur in people with a substance abuse disorder.

The information provided here is based on the scientific and clinical research of Professors Lader, Ashton, and other world renowned experts who have dedicated a significant portion of their life’s work to benzodiazepine research. Some content found on this website (where noted) was created under the guidance and direction of benzodiazepine research expert Professor Malcolm H. Lader, O.B.E., LL.B., Ph.D., M.D., D.Sc., F.R.C. Psych., F. Med Sci., F.L.S., Emeritus Professor of Clinical Psychopharmacology at King’s College, England.

Evidence of benzodiazepine associated adverse effects, brain changes, dependency, and the withdrawal syndrome after long-term use were discovered about a decade after the medication class hit the market in the mid 21st century, when chronic use of them became more prevalent. The potential damage and adverse effects of benzodiazepines were first recognized in official medical literature over 50 years ago by Professor Lader and his colleagues, and later addressed in a clinical research setting by Professor C. Heather Ashton, D.M., F.R.C.P. For reasons unbeknownst to the experts, the seriousness of the problem with benzodiazepines has been minimized, resulting in lack of awareness worldwide among patients and professionals alike. Mismanagement in addressing the problem is commonly reported. Today, however, many organizations such as lader-ashton.org are available to help provide expert information and spread awareness about the phenomenon.

Follow Lader-Ashton